I would hazard a guess and say that Lexaria has given up on fully orally ingestable nicotine products and is now concentrating on proving the viability of a product that can be absorbed through the buccal tissues. It's unclear whether the compounds that are being readied for Altria are of this type.
News 
Market Data 
Discover 
